Biostar Pharma gets FDA clearance of the IND application for a Phase 2 study of Utidelone Injection
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Dyslipidemia is a critical risk factor for cardiovascular diseases
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Glenmark released Picture Post Cards on World Vitiligo Day
Subscribe To Our Newsletter & Stay Updated